MARKET

ARKG

ARKG

ARK Genomic Revolution ETF
BATS

Real-time Quotes | Provided by Morningstar

35.05
-0.67
-1.88%
Closed 16:00 01/17 EST
OPEN
35.95
PREV CLOSE
35.72
HIGH
35.95
LOW
34.95
VOLUME
183.90K
TURNOVER
--
52 WEEK HIGH
36.63
52 WEEK LOW
26.87
TOTAL ASSET
513.17M
YTD YIELD
4.44%
1D
5D
1M
3M
1Y
5Y

Tools for In-Depth Analysis of ARKG, Buy or Sell Stocks and ETFs Commission-Free!

Open a Webull account and fund it to get a free stock

ARKG News

  • Drugmakers getting creative over ways to pay for pricey meds
  • Seeking Alpha - Article.01/13 17:16
  • California mulling private-label generics to address high drug costs
  • Seeking Alpha - Article.01/09 15:05
  • UNG, UGAZ, DGAZ and LABU among weekly ETF movers
  • Seeking Alpha - Article.01/03 22:08
  • End-of-year drug approvals in U.S. associated with more adverse events - study
  • Seeking Alpha - Article.01/03 13:07

More

Profile

Fund Name
ARK Genomic Revolution ETF
Risk
High Risk
Inception Date
2014-10-30
Benchmark
NASDAQ Health Care GR EUR*100.0%
Advisor Company
ARK ETF Trust
Custodian
The Bank of New York Mellon
Manager
Catherine Wood

Asset Allocation

396.32M
  • 99.8388%
  • 0.00%
  • 0.1613%
  • 0.00%

2019 Q3

396.32M

2019 Q2

448.72M

2019 Q1

393.50M

2018 Q4

253.92M

2018 Q3

339.01M

Dividend History

Ex-Div Date
Dividend Per Share
12/27/2019
1.0539
12/27/2018
0.1963
12/27/2017
0.1927